Skip To Main Content

Inspiration and Innovation

Get inspired and stay on the cutting edge of innovation with these resources.

Sort by

Filters

Reset
  • Therapeutical Areas
  • Type of Content
ESC/EAS 2019 Guidelines for the management of dyslipidaemias

ESC/EAS 2019 Guidelines for the management of dyslipidaemias

Caprini Score Responses to Prevent VTE in Patients Undergoing Varicose Vein Surgery

Caprini Score Responses to Prevent VTE in Patients Undergoing Varicose Vein Surgery

VTE Risk Assessment in Surgical Patients

VTE Risk Assessment in Surgical Patients

Advancing therapy in suboptimally controlled basal insulin-treated type 2 diabetes: Clinical outcomes with iGlarLixi versus premix BIAsp 30 in the SoliMix randomized controlled trial.

Advancing therapy in suboptimally controlled basal insulin-treated type 2 diabetes: Clinical outcomes with iGlarLixi versus premix BIAsp 30 in the SoliMix randomized controlled trial.

VTE prophylaxis in medically ill patients

VTE prophylaxis in medically ill patients

Key Learnings in Dyslipidemia by Prof. Kausik Ray - 2021 EAS Congress

Key Learnings in Dyslipidemia by Prof. Kausik Ray - 2021 EAS Congress

Odyssey Outcomes - PVD Sub-analysis

Odyssey Outcomes - PVD Sub-analysis

Why compromise for less: Should PCSK9 inhibitors be initial therapy?

Why compromise for less: Should PCSK9 inhibitors be initial therapy?

Odyssey Outcomes - Total Events Analysis

Odyssey Outcomes - Total Events Analysis

Odyssey outcomes - CVOT mortality sub-analysis

Odyssey outcomes - CVOT mortality sub-analysis

LLTs Exposure Time and Major Vascular Risk Reduction

LLTs Exposure Time and Major Vascular Risk Reduction

Improving Lipid Management for Patients Post-ACS

Improving Lipid Management for Patients Post-ACS